
|Videos|March 24, 2023
Use of Spesolimab in the Treatment of GPP
Author(s)Raj Chovatiya, MD, PhD, MSCI
Dr Raj Chovatiya discusses a recently approved therapeutic agent, spesolimab, as a valuable addition to the GPP treatment landscape.
Advertisement
Episodes in this series

Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement






















